Last update:

HIV & AIDS news

HIV & AIDS

Tackling HIV with machine learning

Hiding behind numerous disguises, HIV has been evading researchers for years, leaving the search for a vaccine as elusive as the virus itself.

HIV & AIDS

Two HIV vaccine trials show proof of concept for pathway to broadly neutralizing antibodies

A decades-long scientific challenge in HIV vaccine development has been finding a way to train the immune system to produce antibodies that can target many variants of the virus. Traditional approaches haven't worked—largely ...

HIV & AIDS

US funding cuts have crippled our HIV work. What's being lost?

The Trump administration's cuts to funding for scientific research have left many scientists reeling and very worried. At the National Institutes of Health in the US, which has an annual budget of US$47 billion to support ...

HIV & AIDS

Unexpected hives reaction seen in trial of mRNA vax against HIV

A safety analysis of mRNA vaccination in a phase 1, randomized, open-label clinical trial evaluated the safety and tolerability of three investigational HIV-1 trimer mRNA vaccines. The study vaccines were found to be generally ...

HIV & AIDS

How a potential HIV cure may affect transmission

A mathematical modeling study coordinated by UMC Utrecht has shown that sustained HIV remission (without rebound) or HIV eradication cure scenarios could consistently reduce new HIV infections among men who have sex with ...

HIV & AIDS

Worm eradication: A surprising ally in the fight against HIV

Researchers from the Munich Tropical Institute, the Tanzanian NIMR-MMRC, DZIF, together with colleagues from Bonn, have discovered a risk factor for HIV infection that has received little attention to date. In an earlier ...